mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.025 |
0.7 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |